Atlas Trials

Role of rhPSMA-7.3 PET/CT Imaging in Men With High-Risk Prostate Cancer Following Conventional Imaging and Associated Changes in Medical Management

Clinical trial NCT05799248 · UNKNOWN

Trial details

NCT number
NCT05799248
Sponsor
MidLantic Urology
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2023-04-27
Primary completion
2024-05-28
Enrollment
113

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.